PharmaForum
Ernesto Zanet, Zdeněk Adam, Krešo Bendelja(Institute of Immunology), Hanjun Tu(Wuhan University), Teresa Lacchin, Gordana Brozović, Nikolaos Tsilimparis(LMU Klinikum), Frédéric Peyrade, Yen-Yi Chou, Nai‐Shun Yao, Pierre‐Yves Bondiau, Alessandra Bearz(Centro di Riferimento Oncologico), P. Rogalla, Chris Braumann(Universitätsklinik Marien Hospital Herne), Luca Balestreri, Vesna Benković(University of Zagreb), Katarina Šakić, Charalampos Menenakos, Salvatore Berretta, R Fisichella, Qingle Liang(Chongqing University), Roberto Orecchia(Istituti di Ricovero e Cura a Carattere Scientifico), Barbara Alicja Jereczek‐Fossa(European Institute of Oncology), Fong-Ching Hsiao, Nada Oršolić(University of Zagreb), Éduardo Bruera(The University of Texas MD Anderson Cancer Center), Isabelle Peyrottes, Juliette Thariat(Centre National de la Recherche Scientifique), Fabijan Knežević, Zhangming Zhou(Shenyang Medical College), Immacolata Izzi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Guglielmo Nasti, Zlatko Hrgović(Croatian Hydrographic Institute), Yung-Chih Wang, Fanny Burel‐Vandenbos, A. Torresin, Patrizia Ortolanik, Umberto Tirellia, Li Zhang(Jiangxi University of Science and Technology), Zhiqiang Li(Jiangxi University of Traditional Chinese Medicine), Dongsheng Li(National University of Defense Technology), Hui Wang(Zhejiang Hospital), Ping‐Ying Chang, Jérôme Barrière(Clinique Saint Jean Languedoc), Te‐Yu Lin, Anica Horvat Knežević(University of Zagreb), Jens Hartmann(Charité - Universitätsmedizin Berlin), Giuseppe Curigliano(European Institute of Oncology), Walter Josef Faßbender, Jun Qing(Taihe Hospital)
Cited by 0
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k